TY  - GEN
AU  - Brandi,Giovanni
AU  - Tavolari,Simona
AU  - Guarnieri,Tiziana
AU  - Di Marco,Mariacristina
AU  - Paterini,Paola
AU  - Macchini,Marina
AU  - Di Girolamo,Stefania
AU  - Papi,Alessio
AU  - De Rosa,Francesco
AU  - Biasco,Guido
TI  - Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study
SN  - 1536-4828
PY  - 2014///0815
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antimetabolites, Antineoplastic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Blotting, Western
KW  - Cell Line
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Deoxycytidine
KW  - Down-Regulation
KW  - Drug Evaluation, Preclinical
KW  - methods
KW  - Enzyme Activation
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - metabolism
KW  - Gabexate
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Interleukin-8
KW  - genetics
KW  - Matrix Metalloproteinase 2
KW  - Matrix Metalloproteinase 9
KW  - NF-kappa B
KW  - antagonists & inhibitors
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-akt
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Serine Proteinase Inhibitors
KW  - Vascular Endothelial Growth Factor A
KW  - Gemcitabine
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/MPA.0b013e3182a6486e
ER  -